-- Poster Presentations to Highlight Company's Ongoing Research Commitment to Schizophrenia and Depression -- DUBLIN, April 30, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of six posters highlighting data from the company's schizophrenia and...
from PR Newswire: //https://ift.tt/2jgZZHX
No comments:
Post a Comment